Literature DB >> 28667470

[30-day mortality after systemic anticancer treatment : Population-based observational study on breast and lung cancer].

Isabella Gruber1, Gerhard G Grabenbauer1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28667470     DOI： 10.1007/s00066-017-1170-5

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  10 in total

1.  Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.

Authors:  Jean-Yves Douillard; Rafael Rosell; Mario De Lena; Francesco Carpagnano; Rodryg Ramlau; Jose Luis Gonzáles-Larriba; Tomasz Grodzki; Jose Rodrigues Pereira; Alain Le Groumellec; Vito Lorusso; Claude Clary; Antonio J Torres; Jabrail Dahabreh; Pierre-Jean Souquet; Julio Astudillo; Pierre Fournel; Angel Artal-Cortes; Jacek Jassem; Leona Koubkova; Patricia His; Marcello Riggi; Patrick Hurteloup
Journal:  Lancet Oncol       Date:  2006-09       Impact factor: 41.316

2.  Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base.

Authors:  Cliff G Robinson; Aalok P Patel; Jeffrey D Bradley; Todd DeWees; Saiama N Waqar; Daniel Morgensztern; Maria Q Baggstrom; Ramaswamy Govindan; Jennifer M Bell; Tracey J Guthrie; Graham A Colditz; Traves D Crabtree; Daniel Kreisel; Alexander S Krupnick; G Alexander Patterson; Bryan F Meyers; Varun Puri
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

Review 3.  Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline.

Authors:  Jennifer J Griggs; Pamela B Mangu; Holly Anderson; Edward P Balaban; James J Dignam; William M Hryniuk; Vicki A Morrison; T May Pini; Carolyn D Runowicz; Gary L Rosner; Michelle Shayne; Alex Sparreboom; Lara E Sucheston; Gary H Lyman
Journal:  J Clin Oncol       Date:  2012-04-02       Impact factor: 44.544

4.  Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index.

Authors:  Marco Colleoni; Sigui Li; Richard D Gelber; Karen N Price; Alan S Coates; Monica Castiglione-Gertsch; Aron Goldhirsch
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

5.  Chemotherapy Use, Performance Status, and Quality of Life at the End of Life.

Authors:  Holly G Prigerson; Yuhua Bao; Manish A Shah; M Elizabeth Paulk; Thomas W LeBlanc; Bryan J Schneider; Melissa M Garrido; M Carrington Reid; David A Berlin; Kerin B Adelson; Alfred I Neugut; Paul K Maciejewski
Journal:  JAMA Oncol       Date:  2015-09       Impact factor: 31.777

6.  Predicting septic complications of chemotherapy: an analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis.

Authors:  J A Radford; W D Ryder; D Dodwell; H Anderson; N Thatcher
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

7.  Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

Authors:  Rodrigo Arriagada; Bengt Bergman; Ariane Dunant; Thierry Le Chevalier; Jean-Pierre Pignon; Johan Vansteenkiste
Journal:  N Engl J Med       Date:  2004-01-22       Impact factor: 91.245

8.  Development and validation of a model predicting short survival (death within 30 days) after palliative radiotherapy.

Authors:  Kent Angelo; Jan Norum; Astrid Dalhaug; Adam Pawinski; Gro Aandahl; Ellinor Haukland; Kirsten Engljähringer; Carsten Nieder
Journal:  Anticancer Res       Date:  2014-02       Impact factor: 2.480

9.  30 day mortality in adult palliative radiotherapy--A retrospective population based study of 14,972 treatment episodes.

Authors:  Katie Spencer; Eva Morris; Emma Dugdale; Alexander Newsham; David Sebag-Montefiore; Rob Turner; Geoff Hall; Adrian Crellin
Journal:  Radiother Oncol       Date:  2015-04-07       Impact factor: 6.280

10.  30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study.

Authors:  Michael Wallington; Emma B Saxon; Martine Bomb; Rebecca Smittenaar; Matthew Wickenden; Sean McPhail; Jem Rashbass; David Chao; John Dewar; Denis Talbot; Michael Peake; Timothy Perren; Charles Wilson; David Dodwell
Journal:  Lancet Oncol       Date:  2016-08-30       Impact factor: 41.316
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.